Advicenne Reports First-Half 2018 Results and Confirms Outlook for 2018
September 20, 2018
Advicenne (Euronext: ADVIC), a French company specializing in the development of therapeutic products for adults and children for the treatment of orphan renal and neurological diseases, today published its first-half financial results as of June 30, 2018 and confirms its operating outlook for 2018…